Concepedia

Author

John C. Lucas

Pfizer (United States)

Also Known As

J. Lucas, John C Lucas, John C. Lucas, John Lucas

11

Publications

298

Citations

7

H-Index

18

Concepts

All Affiliations

Pfizer (United States)
JC

About

John C. Lucas is an author at Pfizer (United States) specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

204

2

Biochemistry

4

4

204

3

Natural Sciences

2

2

58

4

Engineering

1

1

58

5

Chemical Biology

1

1

25

John C. Lucas

×

6

Publications

290

Citations

6

H-Index

YearCitations

Discovery and SAR of 2-aminothiazole inhibitors of cyclin-dependent kinase 5/p25 as a potential treatment for Alzheimer’s disease

Christopher J. Helal, Mark A. Sanner, Christopher B. Cooper,

Bioorganic & Medicinal Chemistry Letters

2004

99

Telescoped Flow Process for the Syntheses of <i>N</i>-Aryl Pyrazoles

Bryan Li, Daniel W. Widlicka, Steven J. Boucher,

Organic Process Research & Development

2012

58

Potent and cellularly active 4-aminoimidazole inhibitors of cyclin-dependent kinase 5/p25 for the treatment of Alzheimer’s disease

Christopher J. Helal, Zhijun Kang, John C. Lucas,

Bioorganic & Medicinal Chemistry Letters

2009

47

Synthesis of Spiropiperidine Lactam Acetyl-CoA Carboxylase Inhibitors

Kim Huard, Scott W. Bagley, Elnaz Menhaji‐Klotz,

The Journal of Organic Chemistry

2012

33

A Concise and Regioselective Synthesis of 1-Alkyl-4-imidazolecarboxylates

Christopher J. Helal, John C. Lucas

Organic Letters

2002

28

Stereoselective Synthesis of <i>cis</i>-1,3-Disubstituted Cyclobutyl Kinase Inhibitors

Christopher J. Helal, Zhijun Kang, John C. Lucas,

Organic Letters

2004

25

Page 1